Why is Jenburkt Pharma falling/rising?

As of 09-Jul, Jenburkt Pharmaceuticals Ltd. is experiencing a price increase, currently at Rs 1,372.00, which reflects a rise of 7.45 (0.55%). The stock has shown a mixed performance recently, with a 1-week decline of 1.58% while achieving a notable 7.86% increase over the past month. Despite touching an intraday low of Rs 1,300, the stock remains close to its 52-week high, just 2.77% away from Rs 1,410. The stock has outperformed its sector by 0.35% today, although there has been a decline in investor participation, with delivery volume falling by 24.12% against the 5-day average. The company benefits from a low debt-to-equity ratio and has demonstrated strong long-term performance, generating a 54.88% return over the past year, which has contributed positively to its recent price movement.
In the broader market context, the stock's short-term performance has been less favorable compared to the benchmark, as it has declined by 1.58% over the past week while the Sensex has increased by 0.15%. However, the stock's year-to-date return of 12.95% significantly outpaces the Sensex's 6.91%, indicating a strong overall performance in the longer term. The company's ability to outperform the BSE500 over various time frames, including the last three years, further highlights its resilience and attractiveness to investors, despite the recent fluctuations in trading volume and price.